Page last updated: 2024-12-05

glutaric anhydride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Glutaric anhydride is a cyclic anhydride derived from glutaric acid. It is a white crystalline solid with a melting point of 56-57 °C. Glutaric anhydride is commonly used as a reagent in organic synthesis. It is a valuable starting material for the preparation of various important compounds, including pharmaceuticals, polymers, and other fine chemicals. Its synthesis typically involves the dehydration of glutaric acid using methods like heating under reduced pressure or using dehydrating agents. Glutaric anhydride has been investigated for its potential applications in various fields. For example, it has been studied as a precursor for the synthesis of polyesters, which are valuable polymers with diverse applications. Additionally, glutaric anhydride has been explored as a building block for the synthesis of pharmaceutical compounds with diverse biological activities. The importance of glutaric anhydride lies in its versatility as a synthetic intermediate and its potential applications in diverse fields, making it a subject of continued research and development.'

glutaric anhydride: RN given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

glutaric anhydride : A cyclic dicarboxylic anhydride that is oxane which carries oxo groups at positions 2 and 6. It is used as an intermediate in the production of pharmaceuticals, corrosion inhibitors, and polymers (E.g. epoxy polyesters). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7940
CHEMBL ID3188341
CHEBI ID167482
SCHEMBL ID19926
MeSH IDM0213149

Synonyms (59)

Synonym
CHEBI:167482
oxane-2,6-dione
pentanedioic acid anhydride
tetrahydropyran-2,6-dione
pyroglutaric acid
2h-pyran-2,6(3h)-dione, dihydro
ai3-06352
einecs 203-593-6
nsc 16640
brn 0110051
anhydrid kyseliny glutarove [czech]
glutaric anhydride
2h-pyran-2, dihydro-
nsc-16640
wln: t6vovtj
glutaric acid anhydride
nsc16640
108-55-4
pentanedioic anhydride
2h-pyran-2,6(3h)-dione, dihydro-
inchi=1/c5h6o3/c6-4-2-1-3-5(7)8-4/h1-3h
dihydro-2h-pyran-2,6(3h)-dione
glutaric anhydride, 95%
STK397450
G0071
AKOS000121028
tetrahydropyran-2,6-dione;dihydro-2h-pyran-2,6(3h)-dione
A801892
NCGC00248238-01
cas-108-55-4
NCGC00254877-01
dtxsid5044362 ,
dtxcid3024362
tox21_300975
unii-63ofi15s80
63ofi15s80 ,
anhydrid kyseliny glutarove
ec 203-593-6
5-17-11-00009 (beilstein handbook reference)
BP-13001
FT-0626733
oxacyclohexane-2,6-dione
dihydro-3h-pyran-2,6-dione
pentahydropyran-2,6-dione
dihydropyran-2,6-dione
SCHEMBL19926
dihydro-pyran-2,6-dione
Q-201164
pentanedioic-d6 anhydride
1219794-53-2
CHEMBL3188341
mfcd00006679
F0001-0173
glutaric anhydride, technical, >=90% (nt)
glutaric anhydride, vetec(tm) reagent grade, 94%
AS-13081
Q11074437
AM1000009
EN300-18018

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dilution with water given by gavage after peroral dosing had no effect on lethal toxicity."( The acute toxicity, primary irritancy and skin sensitizing potential of glutaric anhydride.
Ballantyne, B; Blaszcak, DL; Myers, RC, 1992
)
0.52
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
cyclic dicarboxylic anhydrideAn acid anhydride derived by loss of water between two carboxylic groups in the same molecule so as to close a ring.
oxanesAny organic heteromonocyclic compoundthat is oxane or its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency48.55770.000627.21521,122.0200AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.56)18.7374
1990's2 (11.11)18.2507
2000's6 (33.33)29.6817
2010's5 (27.78)24.3611
2020's4 (22.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.80 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index5.10 (4.65)
Search Engine Demand Index67.13 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]